Mangoceuticals, Inc. Common Stock (MGRX) — Financial Flexibility Index
Mangoceuticals, Inc. Common Stock (MGRX) has a Financial Flexibility Index of -1.54x as of September 2025. Free cash flow of $-1.24 Million (operating CF $-1.24 Million minus capex $4.00) represents -2% of total liabilities ($804.27K). Check Mangoceuticals, Inc. Common Stock (MGRX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mangoceuticals, Inc. Common Stock Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Mangoceuticals, Inc. Common Stock across 4 annual periods. See Mangoceuticals, Inc. Common Stock (MGRX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Mangoceuticals, Inc. Common Stock (2021–2024)
Year-by-year free cash flow to debt coverage for Mangoceuticals, Inc. Common Stock. For the full company profile including market capitalisation, see market value of Mangoceuticals, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.41x | $-4.86 Million | $-4.86 Million | $1.43 Million | ▲ +86.5% |
| 2023 | -25.34x | $-6.99 Million | $-7.00 Million | $276.04K | ▼ -656.7% |
| 2022 | -3.35x | $-1.30 Million | $-1.35 Million | $389.26K | ▼ -614.0% |
| 2021 | 0.65x | $25.58K | $-17.52K | $39.27K | — |